查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462958

微生物组诊断市场,占有率,规模,趋势,行业分析报告:依样本,产品,技术,应用,最终用户,地区,细分市场预测2024-2032 年

Microbiome Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample (Skin, Fecal, Saliva); By Product; By Technology; By Application; By End-User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球微生物组诊断市场规模预计将达到 4.8375 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

对个人化医疗日益增长的需求、不断增加的疾病发病率以及学术界和微生物组行业在微生物组研究方面的合作努力正在推动基于微生物组的诊断市场。由于新兴国家的扩张以及产业参与者在开发新型微生物组技术方面的合作不断加强，微生物组诊断市场预计将出现获利成长。

微生物组商业化是一个多方面的过程，受到各种监管政策和指南的影响。这些法规的製定是为了确保基于微生物组的产品和服务的安全性和有效性。然而，这些法规也可能对基于微生物组的诊断市场的商业化和成长构成重大障碍。监管要求通常需要严格的测试、记录和审批流程，这对于寻求将基于微生物组的产品推向市场的公司来说既耗时又昂贵。

此外，随着微生物组科学的不断发展，监管框架仍在开发或可能发生变化，这使得商业化过程更加复杂。儘管有这些课题，遵守监管标准对于确保消费者安全和维持基于微生物组的产品和服务在市场上的可信度至关重要。

在快速扩展的微生物组研究领域，众多小型创新公司正在为主要利害关係人创造强劲的成长机会。利害关係人对收购微生物组研究公司越来越感兴趣，重点是确定各种疾病的诊断试剂盒和生物标记靶标，包括糖尿病、肝病、肥胖和代谢疾病。市场开发领导者强调策略联盟和伙伴关係，并采用系统性的研究和开发策略来加强其产品线。过去两年，涉及大公司的研究合作和伙伴关係显着增加，反映出微生物组研究在医疗保健及其他领域日益增长的重要性和潜力。

微生物组诊断市场报告亮点

设备领域透过对微生物组样本进行精确分析而在微生物组诊断中发挥关键作用，在 2023 年占据了市场主导地位。

製药和生物技术公司将在 2023 年引领市场并继续保持这一地位，因为它们的主要目标是利用微生物组数据开发创新疗法、个人化医疗和先进益生菌，预计将保持其主导地位。

北美在全球微生物组诊断市场中占据主要收入占有率，见证了显着增长，这主要是由美国和加拿大不断加强的研发力度所推动的。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球微生物组诊断市场洞察

  • 微生物组诊断 - 产业快照
  • 微生物组诊断市场动态
    • 驱动因素和机遇
      • 向个人化医疗过渡
      • 学术机构和微生物组实验室之间加强合作预计将推动对该产品的需求。
    • 限制因素和课题
      • 最终用户融资问题可能会阻碍市场成长
  • PESTLE分析
  • 微生物组诊断产业趋势
  • COVID-19 影响分析

第五章世界市场样本

  • 主要发现
  • 介绍
  • 皮肤
  • 粪便
  • 唾液
  • 其他

第六章依产品划分的世界市场

  • 主要发现
  • 介绍
  • 机器
  • 试剂和试剂盒

第七章依科技划分的世界市场

  • 主要发现
  • 介绍
  • 元转录组学
  • 鸟枪法宏基因体学
  • 16s rRNA测序

第八章依应用划分的世界市场

  • 主要发现
  • 介绍
  • 研究用途
  • 疾病诊断用途

第 9 章最终用户的全球市场

  • 主要发现
  • 介绍
  • 学术研究所
  • 医院
  • 製药和生物技术公司

第10章依地区划分的世界市场

  • 主要发现
  • 介绍
    • 微生物组诊断市场评估，依地区，2019-2032
  • 微生物组诊断市场—北美
    • 北美：微生物组诊断市场（依样本），2019-2032
    • 北美：微生物组诊断市场，依应用划分，2019-2032
    • 北美：微生物组诊断市场（依产品），2019-2032
    • 北美：微生物组诊断市场（依技术），2019-2032
    • 北美：微生物组诊断市场，依最终用户划分，2019-2032 年
    • 微生物组诊断市场—美国
    • 微生物组诊断市场—加拿大
  • 微生物组诊断市场 - 欧洲
    • 欧洲：微生物组诊断市场（依样本），2019-2032
    • 欧洲：微生物组诊断市场，依应用分类，2019-2032
    • 欧洲：微生物组诊断市场（依产品），2019-2032
    • 欧洲：微生物组诊断市场（依技术），2019-2032
    • 欧洲：微生物组诊断市场，依最终用户划分，2019-2032 年
    • 微生物组诊断市场—英国
    • 微生物组诊断市场—法国
    • 微生物组诊断市场—德国
    • 微生物组诊断市场—义大利
    • 微生物组诊断市场—西班牙
    • 微生物组诊断市场—荷兰
    • 微生物组诊断市场—俄罗斯
  • 微生物组诊断市场—亚太地区
    • 亚太地区：微生物组诊断市场（依样本），2019-2032
    • 亚太地区：微生物组诊断市场，依应用划分，2019-2032
    • 亚太地区：微生物组诊断市场（依产品），2019-2032
    • 亚太地区：微生物组诊断市场（依技术），2019-2032
    • 亚太地区：微生物组诊断市场，依最终用户划分，2019-2032 年
    • 微生物组诊断市场 - 中国
    • 微生物组诊断市场 - 印度
    • 微生物组诊断市场—日本
    • 微生物组诊断市场 - 马来西亚
    • 微生物组诊断市场 - 印度尼西亚
    • 微生物组诊断市场—韩国
  • 微生物组诊断市场 - 中东和非洲
    • 中东和非洲：微生物组诊断市场（依样本），2019-2032
    • 中东和非洲：微生物组诊断市场，依应用分类，2019-2032
    • 中东和非洲：微生物组诊断市场（依产品），2019-2032
    • 中东和非洲：微生物组诊断市场（依技术），2019-2032
    • 中东和非洲：微生物组诊断市场，依最终用户划分，2019-2032 年
    • 微生物组诊断市场 - 沙乌地阿拉伯
    • 微生物组诊断市场 - 阿联酋
    • 微生物组诊断市场—以色列
    • 微生物组诊断市场—南非
  • 微生物组诊断市场—拉丁美洲
    • 拉丁美洲：微生物组诊断市场（依样本），2019-2032 年
    • 拉丁美洲：微生物组诊断市场，依应用划分，2019-2032 年
    • 拉丁美洲：微生物组诊断市场（依产品），2019-2032 年
    • 拉丁美洲：微生物组诊断市场（依技术），2019-2032
    • 拉丁美洲：微生物组诊断市场，依最终用户划分，2019-2032 年
    • 微生物组诊断市场—墨西哥
    • 微生物组诊断市场—巴西
    • 微生物组诊断市场—阿根廷

第十一章竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/出版物

第十二章公司简介

  • DNA Genotek
  • Genetic Analysis AS
  • Microba
  • 4D Pharma PLC
  • AOBiome Therapeutics
  • Atlas Biomed
  • BioGaia
  • BIOHM Health
  • Bione Ventures Private Limited
  • DayTwo
  • Enterome
  • Evvy
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group
  • Flightpath Biosciences, Inc
Product Code: PM4709

The global microbiome diagnostics market size is expected to reach USD 483.75 million by 2032, according to a new study by Polaris Market Research. The report "Microbiome Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample (Skin, Fecal, Saliva); By Product; By Technology; By Application; By End-User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising need for personalized medicine, increased illness incidence, and cooperative efforts between academia and the microbiome industry for microbiome research are pushing the market for microbiome-based diagnostics. The microbiome diagnostics market is expected to see profitable growth prospects due to the expansion of emerging nations and the growing cooperation of industry players on the development of novel microbiome technologies.

The commercialization of microbiomes is a multifaceted process influenced by a variety of regulatory policies and guidelines. These regulations are put in place to guarantee the safety and effectiveness of microbiome-based products and services. Still, they can also pose significant hurdles to commercialization and growth in the microbiome-based diagnostics market. Regulatory requirements often demand rigorous testing, documentation, and approval processes, which can be time-consuming and costly for companies seeking to bring microbiome-based products to market.

Additionally, the evolving nature of microbiome science means that regulatory frameworks may still be in development or subject to change, further complicating the commercialization process. Despite these challenges, adherence to regulatory standards is crucial for ensuring consumer safety and maintaining the credibility of microbiome-based products and services in the market.

In the rapidly expanding field of microbiome research, numerous small, innovative companies are creating high-growth opportunities for key stakeholders. There is a growing interest among stakeholders to acquire companies for microbiome research, with a focus on identifying diagnostic kits and biomarker targets for various conditions such as diabetes, liver disorders, obesity, and metabolic disorders. Market leaders are emphasizing strategic collaborations and partnerships to strengthen their product pipelines, employing organized research and development strategies. Over the past two years, there has been a noticeable increase in collaborations and partnerships involving major companies, reflecting the growing importance and potential of microbiome research in healthcare and beyond.

Microbiome Diagnostics Market Report Highlights

The instrument segment dominated the market in 2023, driven by its critical role in microbiome diagnostics by enabling the accurate and precise analysis of microbiome samples.

The pharmaceutical & biotechnology companies segment led the market in 2023 and is expected to maintain its dominance due to their primary goal being to utilize microbiome data to create innovative therapies, personalized medicine, and advanced probiotics.

North America holds a significant revenue share in the global Microbiome Diagnostics market, driven by undergoing substantial growth, largely fueled by heightened research and development endeavors in the United States and Canada.

The global key market players include DNA Genotek, Genetic Analysis AS, Microba, 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, Enterome, and Evvy,

Polaris Market Research has segmented the Microbiome Diagnostics market report based on sample, product, technology, application, end-user, and region:

Microbiome Diagnostics, Sample Outlook (Revenue - USD Million, 2019 - 2032)

  • Skin
  • Fecal
  • Saliva
  • Others

Microbiome Diagnostics, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Instruments
  • Reagents & Kits

Microbiome Diagnostics, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Metatranscriptomics
  • Shot Gun Metagenomics
  • 16s rRNA Sequencing

Microbiome Diagnostics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Research Application
  • Disease Diagnostics Application
  • Metabolic Diseases
  • Gastrointestinal Disorders
  • Others

Microbiome Diagnostics, End-User Outlook (Revenue - USD Million, 2019 - 2032)

  • Academic & Research Institutes
  • Hospitals
  • Pharmaceutical & Biotechnology Companies

Microbiome Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Microbiome Diagnostics Market Insights

  • 4.1. Microbiome Diagnostics - Industry Snapshot
  • 4.2. Microbiome Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Shift Towards Personalized Medicine
      • 4.2.1.2. A rising number of partnerships between academic and microbiome institutes is projected to spur product demand
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Financing problems from end-users are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Microbiome Diagnostics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Microbiome Diagnostics Market, by Sample

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 5.3. Skin
    • 5.3.1. Global Microbiome Diagnostics Market, by Skin, by Region, 2019-2032 (USD Million)
  • 5.4. Fecal
    • 5.4.1. Global Microbiome Diagnostics Market, by Fecal, by Region, 2019-2032 (USD Million)
  • 5.5. Saliva
    • 5.5.1. Global Microbiome Diagnostics Market, by Saliva, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Microbiome Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 6.3. Instruments
    • 6.3.1. Global Microbiome Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 6.4. Reagents & Kits
    • 6.4.1. Global Microbiome Diagnostics Market, by Reagents & Kits, by Region, 2019-2032 (USD Million)

7. Global Microbiome Diagnostics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 7.3. Metatranscriptomics
    • 7.3.1. Global Microbiome Diagnostics Market, by Metatranscriptomics, by Region, 2019-2032 (USD Million)
  • 7.4. Shot Gun Metagenomics
    • 7.4.1. Global Microbiome Diagnostics Market, by Shot Gun Metagenomics, by Region, 2019-2032 (USD Million)
  • 7.4. 16s rRNA Sequencing
    • 7.4.1. Global Microbiome Diagnostics Market, by 16s rRNA Sequencing, by Region, 2019-2032 (USD Million)

8. Global Microbiome Diagnostics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 8.3. Research Application
    • 8.3.1. Global Microbiome Diagnostics Market, by Research Application, by Region, 2019-2032 (USD Million)
  • 8.4. Disease Diagnostics Application
    • 8.4.1. Global Microbiome Diagnostics Market, by Disease Diagnostics Application, by Region, 2019-2032 (USD Million)
    • 8.4.2. Metabolic Diseases
      • 8.4.2.1. Global Microbiome Diagnostics Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
    • 8.4.3. Gastrointestinal Disorders
      • 8.4.3.1. Global Microbiome Diagnostics Market, by Gastrointestinal Disorders, by Region, 2019-2032 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Microbiome Diagnostics Market, by End-User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 9.3. Academic & Research Institutes
    • 9.3.1. Global Microbiome Diagnostics Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
  • 9.4. Hospitals
    • 9.4.1. Global Microbiome Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 9.5. Pharmaceutical & Biotechnology Companies
    • 9.5.1. Global Microbiome Diagnostics Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)

10. Global Microbiome Diagnostics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Microbiome Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. Microbiome Diagnostics Market - North America
    • 10.3.1. North America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.3.2. North America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.3.3. North America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.3.4. North America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.5. North America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.3.6. Microbiome Diagnostics Market - U.S.
      • 10.3.6.1. U.S.: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.3.7. Microbiome Diagnostics Market - Canada
      • 10.3.7.1. Canada: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4. Microbiome Diagnostics Market - Europe
    • 10.4.1. Europe: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.2. Europe.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.3. Europe: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.4. Europe: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.5. Europe: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.6. Microbiome Diagnostics Market - UK
      • 10.4.6.1. UK: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.6.3. UK: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.6.4. UK: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.6.5. UK: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.7. Microbiome Diagnostics Market - France
      • 10.4.7.1. France: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.7.2. France.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.7.3. France: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.7.4. France: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.7.5. France: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.8. Microbiome Diagnostics Market - Germany
      • 10.4.8.1. Germany: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.9. Microbiome Diagnostics Market - Italy
      • 10.4.9.1. Italy: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.10. Microbiome Diagnostics Market - Spain
      • 10.4.10.1. Spain: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.11. Microbiome Diagnostics Market - Netherlands
      • 10.4.11.1. Netherlands: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.4.12. Microbiome Diagnostics Market - Russia
      • 10.4.12.1. Russia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5. Microbiome Diagnostics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.6. Microbiome Diagnostics Market - China
      • 10.5.6.1. China: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.6.2. China.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.6.3. China: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.6.4. China: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.6.5. China: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.7. Microbiome Diagnostics Market - India
      • 10.5.7.1. India: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.7.2. India.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.7.3. India: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.7.4. India: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.7.5. India: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.8. Microbiome Diagnostics Market - Japan
      • 10.5.8.1. Japan: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.9. Microbiome Diagnostics Market - Malaysia
      • 10.5.9.1. Malaysia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.10. Microbiome Diagnostics Market - Indonesia
      • 10.5.10.1. Indonesia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.5.11. Microbiome Diagnostics Market - South Korea
      • 10.5.11.1. South Korea: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.6. Microbiome Diagnostics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.6.6. Microbiome Diagnostics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.6.7. Microbiome Diagnostics Market - UAE
      • 10.6.7.1. UAE: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.6.8. Microbiome Diagnostics Market - Israel
      • 10.6.8.1. Israel: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.6.9. Microbiome Diagnostics Market - South Africa
      • 10.6.9.1. South Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.7. Microbiome Diagnostics Market - Latin America
    • 10.7.1. Latin America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.7.3. Latin America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.7.4. Latin America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.5. Latin America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.7.6. Microbiome Diagnostics Market - Mexico
      • 10.7.6.1. Mexico: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.7.7. Microbiome Diagnostics Market - Brazil
      • 10.7.7.1. Brazil: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
    • 10.7.8. Microbiome Diagnostics Market - Argentina
      • 10.7.8.1. Argentina: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. DNA Genotek
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Genetic Analysis AS
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Microba
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. 4D Pharma PLC
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. AOBiome Therapeutics
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Atlas Biomed
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. BioGaia
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. BIOHM Health
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Bione Ventures Private Limited
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. DayTwo
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Enterome
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Evvy
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Ferring Pharmaceuticals
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Finch Therapeutics Group
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development
  • 12.15. Flightpath Biosciences, Inc
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Benchmarking
    • 12.15.4. Recent Development

List of Tables

  • Table 1 Global Microbiome Diagnostics Market, by Sample, by Region, 2019-2032 (USD Million)
  • Table 2 Global Microbiome Diagnostics Market, by Product, by Region, 2019-2032 (USD Million)
  • Table 3 Global Microbiome Diagnostics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 4 Global Microbiome Diagnostics Market, by End-User, by Region, 2019-2032 (USD Million)
  • Table 5 Global Microbiome Diagnostics Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 6 North America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 7 North America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 8 North America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 9 North America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 10 North America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 11 U.S.: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 12 U.S.: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 13 U.S.: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 14 U.S.: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 15 U.S.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 17 Canada: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 18 Canada: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 19 Canada: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 20 Canada: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 22 Europe: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 23 Europe: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 24 Europe: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 25 Europe: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 26 Germany: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 27 Germany: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 28 Germany: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 29 Germany: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 30 Germany: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 31 France: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 32 France: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 33 France: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 34 France: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 35 France: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 36 UK: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 37 UK: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 38 UK: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 39 UK: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 40 UK: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 41 Italy: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 42 Italy: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 43 Italy: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 44 Italy: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 45 Italy: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 46 Netherlands: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 47 Netherlands: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 48 Netherlands: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 49 Netherlands: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 50 Netherlands: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 51 Spain: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 52 Spain: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 53 Spain: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 54 Spain: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 55 Spain: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 56 Russia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 57 Russia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 58 Russia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 59 Russia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 60 Russia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 66 China: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 67 China: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 68 China: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 69 China: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 70 China: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 71 Japan: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 72 Japan: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 73 Japan: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 74 Japan: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 75 Japan: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 76 India: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 77 India: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 78 India: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 79 India: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 80 India: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 81 Indonesia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 82 Indonesia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 83 Indonesia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 84 Indonesia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 85 Indonesia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 86 Malaysia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 87 Malaysia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 88 Malaysia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 89 Malaysia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 90 Malaysia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 91 South Korea: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 92 South Korea: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 93 South Korea: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 94 South Korea: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 95 South Korea: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 96 Latin America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 97 Latin America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 98 Latin America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 99 Latin America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 100 Latin America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 101 Brazil: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 102 Brazil: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 103 Brazil: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 104 Brazil: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 105 Brazil: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 106 Mexico: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 107 Mexico: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 108 Mexico: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 109 Mexico: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 110 Mexico: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 111 Argentina: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 112 Argentina: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 113 Argentina: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 114 Argentina: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 115 Argentina: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 121 UAE: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 122 UAE: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 123 UAE: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 124 UAE: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 125 UAE: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 131 South Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 132 South Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 133 South Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 134 South Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 135 South Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • Table 136 Israel: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • Table 137 Israel: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • Table 138 Israel: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 139 Israel: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • Table 140 Israel: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Microbiome Diagnostics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Sample
  • Figure 7. Global Microbiome Diagnostics Market, by Sample, 2021 & 2030 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Microbiome Diagnostics Market, by Product, 2021 & 2030 (USD Million)
  • Figure 10. Market by Technology
  • Figure 11. Global Microbiome Diagnostics Market, by Technology, 2021 & 2030 (USD Million)
  • Figure 12. Market by End-User
  • Figure 13. Global Microbiome Diagnostics Market, by End-User, 2021 & 2030 (USD Million)
  • Figure 14. Market by Application
  • Figure 15. Global Microbiome Diagnostics Market, by Application, 2021 & 2030 (USD Million)